FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895954891> ?p ?o ?g. }

• W2895954891 endingPage "6659" @default.
• W2895954891 startingPage "6647" @default.
• W2895954891 abstract "Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy Tianyang Yun,1 Yuxin Liu,2 Shaoqiong Yi,1 Qi Jia,2 Yang Liu,1 Jing Zhou21Department of Thoracic Surgery, Chinese People’s Liberation Army General Hospital, Beijing 100853, People’s Republic of China; 2Department of Chemistry, Capital Normal University, Beijing 100048, People’s Republic of China Background: Utilizing the permeability enhancement and irreversible biomolecule denaturation caused by hyperthermia, photothermal-chemo synergistic therapy has shown great potential in clinical cancer treatment.Purpose: The objective of this study was to provide a novel controlled drug release method to improve the efficiency of photothermal-chemo synergistic therapy.Patients and methods: HCT116 tumor-bearing mice were selected as modal for the study of cancer theranostics efficiency. The T2 to T1 magnetic resonance imaging contrast switch was studied in vivo. Analyses of the tumor growth of mice were carried out to evaluate the tumor therapy efficiency.Results: we developed novel artificially controlled degradable Co3O4 nanoparticles and explored their potential in drug delivery/release. In the presence of ascorbic acid (AA), the designed nanomaterials can be degraded via a redox process and hence release the loaded drugs. Importantly, the AA, in the lack of l-gulonolactone oxidase, cannot be synthesized in the body of typical mammal including human, which suggested that the degradation process can be controlled artificially. Moreover, the obtained nanoparticles have outstanding photothermal conversion efficiency and their degradation can also result in an magnetic resonance imaging contrast enhancement switch from T2 to T1, which benefits the cancer theranostics.Conclusion: Our results illustrated that the artificially controlled degradable nanoparticles can serve as an alternative candidate for controllable drug release as well as a platform for highly efficient photothermal-chemo synergistic cancer theranostics.Keywords: photothermal, degradable, controllable drug release, synergistic therapy, MRI" @default.
• W2895954891 created "2018-10-26" @default.
• W2895954891 creator A5003376619 @default.
• W2895954891 creator A5003890695 @default.
• W2895954891 creator A5042830817 @default.
• W2895954891 creator A5043132063 @default.
• W2895954891 creator A5056348970 @default.
• W2895954891 creator A5084023767 @default.
• W2895954891 date "2018-10-01" @default.
• W2895954891 modified "2023-10-01" @default.
• W2895954891 title "Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy" @default.
• W2895954891 cites W1965118563 @default.
• W2895954891 cites W2010491774 @default.
• W2895954891 cites W2011858664 @default.
• W2895954891 cites W2039233074 @default.
• W2895954891 cites W2100380402 @default.
• W2895954891 cites W2101692115 @default.
• W2895954891 cites W2103581484 @default.
• W2895954891 cites W2154300885 @default.
• W2895954891 cites W2189497698 @default.
• W2895954891 cites W2219892614 @default.
• W2895954891 cites W2263983128 @default.
• W2895954891 cites W2312906277 @default.
• W2895954891 cites W2465532148 @default.
• W2895954891 cites W2473468903 @default.
• W2895954891 cites W2531732275 @default.
• W2895954891 cites W2535438112 @default.
• W2895954891 cites W2564809101 @default.
• W2895954891 cites W2568851997 @default.
• W2895954891 cites W2592205401 @default.
• W2895954891 cites W2604865416 @default.
• W2895954891 cites W2611363212 @default.
• W2895954891 cites W2615517716 @default.
• W2895954891 cites W2623975746 @default.
• W2895954891 cites W2624271835 @default.
• W2895954891 cites W2735178204 @default.
• W2895954891 cites W2740894095 @default.
• W2895954891 cites W2741139537 @default.
• W2895954891 cites W2745729112 @default.
• W2895954891 cites W2755938262 @default.
• W2895954891 cites W2767204017 @default.
• W2895954891 cites W2799691631 @default.
• W2895954891 cites W2884871899 @default.
• W2895954891 doi "https://doi.org/10.2147/ijn.s182206" @default.
• W2895954891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6205544" @default.
• W2895954891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30425480" @default.
• W2895954891 hasPublicationYear "2018" @default.
• W2895954891 type Work @default.
• W2895954891 sameAs 2895954891 @default.
• W2895954891 citedByCount "5" @default.
• W2895954891 countsByYear W28959548912021 @default.
• W2895954891 countsByYear W28959548912022 @default.
• W2895954891 countsByYear W28959548912023 @default.
• W2895954891 crossrefType "journal-article" @default.
• W2895954891 hasAuthorship W2895954891A5003376619 @default.
• W2895954891 hasAuthorship W2895954891A5003890695 @default.
• W2895954891 hasAuthorship W2895954891A5042830817 @default.
• W2895954891 hasAuthorship W2895954891A5043132063 @default.
• W2895954891 hasAuthorship W2895954891A5056348970 @default.
• W2895954891 hasAuthorship W2895954891A5084023767 @default.
• W2895954891 hasBestOaLocation W28959548911 @default.
• W2895954891 hasConcept C12554922 @default.
• W2895954891 hasConcept C126838900 @default.
• W2895954891 hasConcept C136229726 @default.
• W2895954891 hasConcept C143409427 @default.
• W2895954891 hasConcept C150903083 @default.
• W2895954891 hasConcept C155672457 @default.
• W2895954891 hasConcept C171250308 @default.
• W2895954891 hasConcept C182606246 @default.
• W2895954891 hasConcept C185592680 @default.
• W2895954891 hasConcept C192562407 @default.
• W2895954891 hasConcept C207001950 @default.
• W2895954891 hasConcept C2779820397 @default.
• W2895954891 hasConcept C502942594 @default.
• W2895954891 hasConcept C71924100 @default.
• W2895954891 hasConcept C86803240 @default.
• W2895954891 hasConceptScore W2895954891C12554922 @default.
• W2895954891 hasConceptScore W2895954891C126838900 @default.
• W2895954891 hasConceptScore W2895954891C136229726 @default.
• W2895954891 hasConceptScore W2895954891C143409427 @default.
• W2895954891 hasConceptScore W2895954891C150903083 @default.
• W2895954891 hasConceptScore W2895954891C155672457 @default.
• W2895954891 hasConceptScore W2895954891C171250308 @default.
• W2895954891 hasConceptScore W2895954891C182606246 @default.
• W2895954891 hasConceptScore W2895954891C185592680 @default.
• W2895954891 hasConceptScore W2895954891C192562407 @default.
• W2895954891 hasConceptScore W2895954891C207001950 @default.
• W2895954891 hasConceptScore W2895954891C2779820397 @default.
• W2895954891 hasConceptScore W2895954891C502942594 @default.
• W2895954891 hasConceptScore W2895954891C71924100 @default.
• W2895954891 hasConceptScore W2895954891C86803240 @default.
• W2895954891 hasLocation W28959548911 @default.
• W2895954891 hasLocation W28959548912 @default.
• W2895954891 hasLocation W28959548913 @default.
• W2895954891 hasLocation W28959548914 @default.
• W2895954891 hasOpenAccess W2895954891 @default.
• W2895954891 hasPrimaryLocation W28959548911 @default.
• W2895954891 hasRelatedWork W1560638292 @default.

• next